Rome Resources (AIM: RMR), the DRC-focused tin and copper explorer, was notified on 15 December 2025 that Paul Barrett, Chief Executive Officer, purchased 10,000,000 ordinary shares of 0.1 pence each in
Rome Resources (AIM: RMR), the DRC-focused tin and copper explorer, was notified on 15 December 2025 that Paul Barrett, Chief Executive Officer, purchased 10,000,000 ordinary shares of 0.1 pence each in
Genflow Completes Dosing Phase of Canine Gene Therapy Trial No Adverse Events Reported During Administration
The FTSE 100 closed the week down 0.6% after data from the Office for National Statistics showed the UK economy contracted by 0.1%. European markets also finished in negative territory,
Genflow to Attend the 44th Annual J.P. Morgan Healthcare Conference
Tap Global Group (TAP), an innovative digital finance hub that brings money payments and crypto settlement services together in a single user-friendly app, announced the launch of its Bitcoin Treasury as
FTSE 100 Falls 81 Points as Trump’s Tariff Threat Sparks Global Sell-Off. The FTSE 100 closed 81 points lower at 9,427 on Friday, as global markets fell sharply following Donald
Alliance News: Hays (HAS) net fees are down 8% on-year in the first quarter ended September 30, on an actual and like for like basis, with Temp & Contracting fees down
Update on Animal Health Program
Zak Mir takes a charting look at the latest requests, including Arc, Genflow, Upland and Wishbone.
Genflow Biosciences Raises £440,000 Through Alternative Share Placement.
London’s blue-chip FTSE 100 index closed 11 points lower at 9,216 on Friday, leaving it down around 0.7% for the week. The FTSE 250 mid-cap index shed 0.6%, with Raspberry
Genflow Biosciences PLC (LON: GENF) has submitted a formal request for examination of its patent application in China relating to proprietary SIRT6 variants designed for the treatment of Non-Alcoholic Steatohepatitis